AI assistant
BIODESIX INC — Director's Dealing 2022
Dec 22, 2022
34472_dirs_2022-12-22_1045437c-e681-4b77-a03d-d335af627221.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2022-12-21
Reporting Person: Kayyem Jon Faiz (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-21 | Common Stock | M | 31619 | — | Acquired | 31619 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-21 | Restricted Stock Units | $ | M | 31619 | Disposed | Common Stock (31619) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 173913 | Indirect |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2: These securities are directly owned by The Jon Faiz Kayyem Revocable Trust, of which Jon Faiz Kayyem and his spouse serve as co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
F3: These restricted stock units vested in full on December 5, 2022 and were settled in shares of Common Stock on December 21, 2022. These restricted stock units had no expiration date.